🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with T2DM lac a sufficient incretin response after oral glucose in...
Status
Completed
Location
Endokrinologisk afd. J, Herlev Hospital
Start Date
2007-10
Trial ID
NCT00529048
Treatments Being Tested
Glucose-dependent insulinotropic polypeptide (GIP) is a gut-derived increti...
Status
Completed
Location
Clinical Metabolic Physiology
Start Date
2018-06-12
Trial ID
NCT04792762
Treatments Being Tested
Incretin hormones (GLP-1 and GIP) released from the intestine in response t...
Status
Completed
Location
Rigshospitalet
Start Date
2012-09
Trial ID
NCT01749163
In patients with type 2 diabetes, the incretin hormone glucose-dependent in...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT02673554
Treatments Being Tested
This project will characterize the physiological effect of the hormones, GI...
Status
Completed
Location
Center for Clinical Metabolic Research, Gentofte Hospital
Start Date
2023-01-04
Trial ID
NCT06194955
Human volunteers will be stratified by oral glucose tolerance status: norma...
Status
Completed
Location
Rigshospitalet
Start Date
2013-01
Trial ID
NCT01607931
Treatments Being Tested
Patients with end-stage renal disease (ESRD) have a high prevalence of impa...
Status
Completed
Location
Department of Nephrology, Rigshospitalet
Start Date
2014-09
Trial ID
NCT02237521
Treatments Being Tested
This clinical, randomized, cross-over study in obese healthy subjects aimed...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00774488
Treatments Being Tested
This study investigates how the naturally occurring gut hormones GIP and GL...
Status
Recruiting
Location
Copenhagen University Hospital - Rigshospitalet
Start Date
2026-03-12
Trial ID
NCT07398300
Treatments Being Tested
Elevations of blood glucose and lipid are thought to be deleterious to the ...
Status
Completed
Location
Centre of Inflammation and Metabolism, Rigshospitalet
Start Date
2011-04
Trial ID
NCT01375270
Treatments Being Tested